Pharmaceuticals and biotechnology firms make up a multi-billion dollar industry that depends on the strategic use of science, technology, information and intellectual capital. To compete and excel, organizations need scientists, engineers and technologists who understand the business drivers that determine success and failure — and they need leaders in finance, marketing and operations who understand the processes and principles behind scientific discovery and development. For scientists, engineers and IT leaders in pharmaceutical, biomedical and biotechnology organizations, EMTM offers the chance to examine your own industry in greater depth — and to broaden your understanding of technologies in other areas that have an impact on advances in pharmaceutical and biotechnology.

More than 20 percent of current students work in the biotech/pharmaceutical/health sector. They take advantage of multiple courses in EMTM’s Biopharmaceutical and Biotechnology area, such as Drug Discovery, Introduction to Biotechnology and BioNanotechnology, and Medicine and Biotechnology — as well as EMTM's management courses and a host of electives and seminars in other technologies, from Advanced Materials and Robotics to Data Mining, IT Strategy and IT Security and Privacy.

Representative Organizations

Companies and organizations where EMTM students and
graduates have worked include:
AstraZeneca Pharmaceutical LP Microsoft Corporation (Life Sciences)
Aton Pharmaceuticals Pfizer Inc.
Aventis Pasteur Pharmacia Corp
Becton Dickinson and Company (BD) Phillips Medical Systems - Phillips Ultrasound
Bristol-Myers Squibb Purdue Pharmaceuticals
Centocor Sanofi-Aventis
Ciba Schering-Plough
GlaxoSmithKline Shire Pharmaceuticals
ImClone Systems, Inc. Siemens Medical
Immunomedics, Inc. Stryker Orthopaedics
Johnson & Johnson University of Pennsylvania Medical System
Medtronic, USA Wyeth Pharmaceuticals
Merck & Co., Inc.